Giordano Michael F

CIK 00017339152 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001733915

Recent Transactions

33 trades

Disposition from Tender
RAPT Therapeutics, Inc.$RAPT
Common Stock
2026-03-03−4,956→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−938→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−938→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−799→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−824→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−32,229→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−4,561→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−1,618→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−1,063→ 0 total
Disposition to Issuer
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2026-03-03−402→ 0 total
Award
RAPT Therapeutics, Inc.$RAPT
Common Stock
2026-01-30+4,956→ 4,956 total
Award
RAPT Therapeutics, Inc.$RAPT
Director Stock Option (right to buy)
2025-05-29+257,832→ 257,832 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2024-05-22+36,490→ 36,490 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2023-05-24+12,940→ 12,940 total
Disposition to Issuer
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-12−8,060→ 8,994 total
Disposition to Issuer
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-12−8,994→ 0 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2022-05-25+8,500→ 8,500 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2022-05-17+41,006→ 41,006 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2022-05-17+8,994→ 17,054 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2022-03-31$16.80/sh+3,213→ 3,213 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2021-06-11+40,559→ 40,559 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2021-06-11+8,060→ 8,060 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2021-05-28+7,500→ 7,500 total
Exercise/Conversion
RAPT Therapeutics, Inc.$RAPT
Common Stock
2020-06-25$6.18/sh+10,069→ 10,069 total
Exercise/Conversion
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2020-06-25−8,944→ 6,390 total
Exercise/Conversion
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2020-06-25−10,069→ 6,597 total
Exercise/Conversion
RAPT Therapeutics, Inc.$RAPT
Common Stock
2020-06-25$12.00/sh+8,944→ 8,944 total
Sale
RAPT Therapeutics, Inc.$RAPT
Common Stock
2020-06-25$33.37/sh−19,013→ 0 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2020-06-18+7,500→ 7,500 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2020-05-29+14,013→ 14,013 total
Award
RAPT Therapeutics, Inc.$RAPT
Stock Option (right to buy)
2019-10-30+15,334→ 15,334 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2019-05-31+17,633→ 17,633 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2018-03-08+25,000→ 25,000 total

Companies

Recent Filings

Address

C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov